Saturday, June 7, 2014

Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension...

Background: Fingolimod is the first oral immunomodulatory therapy approved for highly acti http://t.co/BQq7zJQnzz

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/BQq7zJQnzz
Posted by at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)